IP Library › Granted Patent US 10,888,579
Granted Patent B2
US 10,888,579 · App. 13/932,051 · Granted Jan 12, 2021

Compositions for conferring tolerance to viral disease in social insects, and the use thereof

Inventors: Nitzan Paldi (Moshav Bar Giora, IL); Gal Yarden (St. Louis, MO)
Assignee: BEEOLOGICS INC.
A61K31/713C12N15/113C12N15/1131C12N2310/14C12N2770/22022
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,888,579
App. No.
13/932,051
Granted
Jan 12, 2021
Kind
B2
Abstract

Compositions and methods for reducing susceptibility to infectious disease in bees using RNA interference technology, and more particularly, prevention and treatment of viral infections in honeybees such as Israel acute paralysis virus (IAPV) by feeding of pathogen-specific dsRNA. Further, multiple-pathogen specific dsRNA is disclosed.

Claims (21)

1. A method for increasing the tolerance of an adult bee to a disease caused by at least one bee pathogen, comprising feeding the adult bee an effective amount of a bee-ingestible composition comprising bee feed and a double stranded ribonucleic acid (dsRNA) comprising an RNA sequence capable of hybridizing to an mRNA transcript encoding a polypeptide or an RNA target sequence of the at least one bee pathogen, thereby increasing the tolerance of the adult bee to the disease, wherein the dsRNA is a naked dsRNA and the bee-ingestible composition does not comprise a transfection promoting agent.

2. The method of claim 1 , wherein the at least one bee pathogen is selected from the group consisting of Acute Bee Paralysis Virus (ABPV), Kashmir Bee Virus (KBV), Sacbrood virus (SBV), Black queen cell virus (BQCV), Kakugo virus (KV), Deformed wing virus (DWV), and Israel acute paralysis virus (IAPV).

3. The method of claim 1 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 47.

4. The method of claim 1 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 50.

5. The method of claim 1 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 24.

6. The method of claim 1 , wherein the dsRNA is selected from the group consisting of siRNA, shRNA, and miRNA.

7. The method of claim 1 , wherein the bee-ingestible composition is in solid form.

8. The method of claim 1 , wherein the bee-ingestible composition is in liquid form.

9. The method of claim 1 , wherein the bee-ingestible composition comprises a protein.

10. A bee-ingestible composition comprising bee feed and a double stranded ribonucleic acid (dsRNA) comprising an RNA sequence capable of hybridizing to an mRNA transcript encoding a polypeptide or an RNA target sequence of at least one bee pathogen,

wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO:24, SEQ ID NO:47, or SEQ ID NO:50, and

wherein the dsRNA is a naked dsRNA and the bee-ingestible composition does not comprise a transfection promoting agent, and whereby an adult bee fed with the bee-ingestible composition increases its tolerance to a disease caused by the at least one bee pathogen.

11. The bee-ingestible composition of claim 10 , wherein the at least one bee pathogen is selected from the group consisting of Acute Bee Paralysis Virus (ABPV), Kashmir Bee Virus (KBV), Sacbrood virus (SBV), Black queen cell virus (BQCV), Kakugo virus (KV), Deformed wing virus (DWV), and Israel acute paralysis virus (IAPV).

12. The bee-ingestible composition of claim 10 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 47.

13. The bee-ingestible composition of claim 10 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 50.

14. The bee-ingestible composition of claim 10 , wherein the dsRNA comprises an RNA sequence that is complementary to at least 21 nucleotides of a nucleotide sequence set forth in SEQ ID NO: 24.

15. The bee-ingestible composition of claim 10 , wherein the bee-ingestible composition is in solid form.

16. The bee-ingestible composition of claim 10 , wherein the bee-ingestible composition is in liquid form.

17. The bee-ingestible composition of claim 10 , wherein the bee-ingestible composition comprises a protein.

18. The bee-ingestible composition of claim 10 , wherein the bee-ingestible composition comprises a carbohydrate or sugar supplement.

19. The bee-ingestible composition of claim 10 , wherein the dsRNA is selected from the group consisting of siRNA, shRNA, and miRNA.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2021
From: BEEOLOGICS, INC.
To: GREENLIGHT BIOSCIENCES, INC.
Reel/Frame 056799/0229 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2013
From: PALDI, NITZAN; YARDEN, GAL
To: BEEOLOGICS INC.
Reel/Frame 030945/0377 →
Continuity (4)
Continuation 13332430 · Dec 21, 2011
Continuation 12222949 · Aug 20, 2008
Provisional Application 60996244 · Nov 7, 2007
Related Publication 20130289097A1 · Oct 31, 2013